摘要
Background Alzheimer＇s disease （AD） is a neurodegenerative disorder and the leading cause of dementia in the elderly. The two hallmark lesions in AD brain are deposition of amyloid plaques and neurofibrillary tangles （NFTs）. Hypercholesteremia is one of the risk factors of AD. But its role in the pathogenesis of AD is largely unknown. The aim of this study was to investigate the relationship between hypercholesteremia and tau phosphorylation or β-amyloid （Aβ）, and evaluate the effect of atorvastatin on the level of tau phosphorylation and Aβ in the brains of rats fed with high cholesterol diet. Methods Sprague-Dawley （SD） rats were randomly divided into normal diet control group, high cholesterol diet group, and high cholesterol diet plus atorvastatin （Lipitor, 15 mg.kg^-1 .d^-1） treated group. Blood from caudal vein was collected to measure total cholesterol （TC）, triglyceride （TG）, low density lipoprotein （LDL） and high-density lipoprotein （HDL） at the end of the 3th and the 6th months by an enzymatic method. The animals were sacrificed 6 months later and brains were removed. All left brain hemispheres were fixed for immunohistochemistry. Hippocampus and cerebral cortex were separated from right hemispheres and homogenized separately. Tau phosphorylation and Aβ in the brain tissue were determined by Western blotting （using antibodies PHF-1 and Tau-1） and anti-Aβ40/anti-Aβ42, respectively. Results We found that high cholesterol diet led to hypercholesteremia of rats as well as hyperphosphorylation of tau and increased Aβ level in the brains. Treatment of the high cholesterol diet fed rats with atorvastatin prevented the changes of both tau phosphorylation and Aβ level induced by high cholesterol diet. Conclusions Hypercholesteremia could induce tau hyperphosphorylation and Aβ production in rat brain. Atorvastatin could inhibit tau hyperphosphorylation and decrease Aβ generation. It may play a protective role in the patho-process of hypercholesteremia-induced neurodegeneration in the brain.
Background Alzheimer＇s disease （AD） is a neurodegenerative disorder and the leading cause of dementia in the elderly. The two hallmark lesions in AD brain are deposition of amyloid plaques and neurofibrillary tangles （NFTs）. Hypercholesteremia is one of the risk factors of AD. But its role in the pathogenesis of AD is largely unknown. The aim of this study was to investigate the relationship between hypercholesteremia and tau phosphorylation or β-amyloid （Aβ）, and evaluate the effect of atorvastatin on the level of tau phosphorylation and Aβ in the brains of rats fed with high cholesterol diet. Methods Sprague-Dawley （SD） rats were randomly divided into normal diet control group, high cholesterol diet group, and high cholesterol diet plus atorvastatin （Lipitor, 15 mg.kg^-1 .d^-1） treated group. Blood from caudal vein was collected to measure total cholesterol （TC）, triglyceride （TG）, low density lipoprotein （LDL） and high-density lipoprotein （HDL） at the end of the 3th and the 6th months by an enzymatic method. The animals were sacrificed 6 months later and brains were removed. All left brain hemispheres were fixed for immunohistochemistry. Hippocampus and cerebral cortex were separated from right hemispheres and homogenized separately. Tau phosphorylation and Aβ in the brain tissue were determined by Western blotting （using antibodies PHF-1 and Tau-1） and anti-Aβ40/anti-Aβ42, respectively. Results We found that high cholesterol diet led to hypercholesteremia of rats as well as hyperphosphorylation of tau and increased Aβ level in the brains. Treatment of the high cholesterol diet fed rats with atorvastatin prevented the changes of both tau phosphorylation and Aβ level induced by high cholesterol diet. Conclusions Hypercholesteremia could induce tau hyperphosphorylation and Aβ production in rat brain. Atorvastatin could inhibit tau hyperphosphorylation and decrease Aβ generation. It may play a protective role in the patho-process of hypercholesteremia-induced neurodegeneration in the brain.
